SCHEMBL2516256

SCHEMBL2516256

CCCCCCCC1=NCCN1C

nearest known ligand 0.49

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
HTR1D P28221 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
GNAI3 P08754 1/20 0.36
GNAO1 P09471 1/20 0.36
GNAI1 P63096 1/20 0.36
SCD O00767 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10948416 1.00 ADRA2A (0.38) ADRA2AADRA2BADRA2CHTR1DMEN1
SCHEMBL2511670 1.00 ADRA2A (0.38) ADRA2AADRA2BADRA2CHTR1DMEN1
SCHEMBL6292172 1.00 ADRA2A (0.38) ADRA2AADRA2BADRA2CHTR1DMEN1
SCHEMBL2512263 1.00 ADRA2A (0.38) ADRA2AADRA2BADRA2CHTR1DMEN1
SCHEMBL6660516 0.92 HTR1D (0.40) ADRA2AADRA2BADRA2CHTR1DMEN1
SCHEMBL989255 0.92 ADRA2A (0.42) ADRA2AADRA2BADRA2CHTR1D
SCHEMBL9398117 0.90 FAAH (0.42)
SCHEMBL9398124 0.90 FAAH (0.42)
Hydrochloric Acid SCHEMBL2417762 0.90 ADRA2A (0.41) ADRA2AADRA2BADRA2CHTR1DMEN1
SCHEMBL12593807 0.87 ALDH1A1 (0.38) MEN1KMT2AGNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5870275-A CONTAINING A QUATERNARY AMIDINE GROUP SANYO CHEMICAL INDUSTRIES, LTD. (JP) 1999-02-09 US claimed
EP-0296199-A1 HETEROCYCLIC COMPOUNDS FOR TRANSDERMAL USE RAJADHYAKSHA, Vithal J. (US) 1988-12-28 EP claimed
WO-1988004938-A1 HETEROCYCLIC COMPOUNDS FOR TRANSDERMAL USE RAJADHYAKSHA VITHAL J (US) 1988-07-14 WO claimed
WO-2026105670-A1 ELECTROLYTIC CAPACITOR AND METHOD FOR MANUFACTURING ELECTROLYTIC CAPACITOR パナソニックIPマネジメント株式会社 2026-05-21 WO disclosed
US-20260058067-A1 ELECTROLYTIC CAPACITOR AND METHOD FOR MANUFACTURING ELECTROLYTIC CAPACITOR PANASONIC IP MAN CO LTD (JP) 2026-02-26 US disclosed
US-20260038745-A1 DISPERSION FOR USE IN MANUFACTURING ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR MANUFACTURING METHOD, AND ELECTROLYTIC CAPACITOR PANASONIC IP MAN CO LTD (JP) 2026-02-05 US disclosed
US-12542245-B2 Electrolytic capacitor PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2026-02-03 US disclosed
US-20260011508-A1 ELECTROLYTIC CAPACITOR AND PRODUCTION METHOD THEREFOR PANASONIC IP MAN CO LTD (JP) 2026-01-08 US disclosed
US-20250308806-A1 ELECTROLYTIC CAPACITOR PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2025-10-02 US disclosed
US-20250308805-A1 ELECTROLYTIC CAPACITOR PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2025-10-02 US disclosed
US-12431295-B2 Electrolytic capacitor with improved equivalent series and resistance and production method therefor PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2025-09-30 US disclosed
CN-1225495-A Electrolytic capacitor and method for making same MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) 1999-08-11 CN disclosed
US-5870275-A CONTAINING A QUATERNARY AMIDINE GROUP SANYO CHEMICAL INDUSTRIES, LTD. (JP) 1999-02-09 US disclosed
CN-1039264-C Electrolytic solution and electrochemical element prepared therefrom SANYO CHEMICAL IND LTD (JP) 1998-07-22 CN disclosed
CN-1117323-A Electrolytic solution and electrochemical element prepared therefrom SANYO CHEMICAL IND LTD (JP) 1996-02-21 CN disclosed
EP-0684620-A1 ELECTROLYTIC SOLUTION AND ELECTROCHEMICAL ELEMENT PREPARED THEREFROM SANYO CHEMICAL INDUSTRIES, LTD. (JP) 1995-11-29 EP disclosed
US-5030629-A Transdermal Administration Of Cardiovascular Agents THERAPEUTIC PATCH RESEARCH N.V. 1991-07-09 US disclosed
US-4876249-A TOPICAL; TRANSDERMAL, SYSTEMIC; FLUOCINOLINE ACETONIDE AND IMIDAZOLINE OR OXAZOLINE PENETRATION ENHANCER MIXTURE; THERAPEUTIC DRUGS THERAPEUTIC PATCH RESEARCH N.V. 1989-10-24 US disclosed
EP-0296199-A1 HETEROCYCLIC COMPOUNDS FOR TRANSDERMAL USE RAJADHYAKSHA, Vithal J. (US) 1988-12-28 EP disclosed
WO-1988004938-A1 HETEROCYCLIC COMPOUNDS FOR TRANSDERMAL USE RAJADHYAKSHA VITHAL J (US) 1988-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260038745-A1 DISPERSION FOR USE IN MANUFACTURING ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR MANUFACTURING METHOD, AND ELECTROLYTIC CAPACITOR RPS21, CNTN1, RAD54L ADRA2A 4656/4885ADRA2B 4316/4885ADRA2C 4737/4885
US-12542245-B2 Electrolytic capacitor TPO, PDK1, ACP1 ADRA2A 4184/4885ADRA2B 4506/4885ADRA2C 4208/4885
US-20260058067-A1 ELECTROLYTIC CAPACITOR AND METHOD FOR MANUFACTURING ELECTROLYTIC CAPACITOR CNTN1, RAD54L, RPS21 ADRA2A 4664/4885ADRA2B 4411/4885ADRA2C 4700/4885
US-20260011508-A1 ELECTROLYTIC CAPACITOR AND PRODUCTION METHOD THEREFOR ADH1C, ALDOA, PDK1 ADRA2A 2624/4885ADRA2B 2864/4885ADRA2C 1788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.